About the speakers

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
55 presentations

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
53 presentations

Doctor Benjamin Morgan Scirica

Brigham and Women's Hospital, Boston (United States of America)
11 presentations
0 follower

3 more presentations in this session

New dimensions in cardiovascular risk: exploring the latest cardiovascular outcomes trials in type 2 diabetes

Speaker: Doctor M. Kosiborod (Kansas City, US)


Analysing the advantages of glucagon-like peptide-1 receptor agonists/sodium-glucose cotransporter 2 inhibitors in high vs. low cardiovascular disease risk

Speaker: Professor J. Deanfield (London, GB)


Exploring the future role of glucagon-like peptide-1 receptor agonists in cardiovascular disease risk reduction

Speaker: Doctor B. Scirica (Boston, US)


Access the full session

Experts on the spot: exploring new dimensions in glucagon-like peptide-1 receptor agonists and cardiovascular risk

Speakers: Doctor M. Kosiborod, Professor J. Deanfield, Doctor B. Scirica, Doctor M. Kosiborod, Professor J. Deanfield...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by